SelectQuote Looks To Escape Investors' Kickback Probe Suit

By Sydney Price · March 18, 2026, 9:28 PM EDT

SelectQuote has asked a New York federal judge to dismiss a proposed class action accusing it of harming investors by concealing a kickback scheme, which is currently the subject of a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

Pahlkotter v. SelectQuote, Inc. et al

Case Number

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

August 11, 2025

Recent Articles By Sydney

March 05, 2026
Drugmaker Aquestive Hit With Suit Over FDA Approval Delay
March 03, 2026
BioAge Investors Lose Last Bid At Obesity Drug-Linked Suit
February 03, 2026
Masimo Investors' $34M Deal In Revenue Suit Gets Initial OK
January 30, 2026
SelectQuote Execs Face Investor Suit Over Kickback Probe
January 16, 2026
SEC Fines Biopharma Co. Execs Over Hidden FDA Findings
January 16, 2026
Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit
January 09, 2026
Ex-Doximity Exec Cops To $2.5M Insider Trading Scheme
January 08, 2026
Ardent Health Investors Sue Over Revenue Accounting Issues
December 12, 2025
Molina Investor Sues Board Over Insurer's Guidance Cuts
December 10, 2025
Diagnostic Co. Agrees To Oversight Reforms In Derivative Suit